参考文献/References:
［1］McKenna S,Eatock M.The medical management of pancreatic cancer:A review.The Oncologist,2003,8(2):149-160.
［2］赵平.我国胰腺癌诊治策略的研究.胰腺病学,2002,2(4):193-195.
［3］Smith JP,Stock E,Orenberg EK,et al.Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts.Anticancer Drugs,1995,6(6):717-726.
［4］Gagner M,Milone L,Turner P.Laparoscopic surgery for pancreatic tumors,an uptake.Minerva Chir,2004,59(2):165-173.
［5］Taschereau R,Roy R,Pouliot J.Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic X-rays from its constitutive materials.Med P Hys,2002,29:1397-1402.
［6］Tapen EM,Blasko JC,Grimm PD,et al.Reduction of radioactive seed embolization to the lung following prostate brachytherapy.Int J Radiant Oncol Biol Phys,1998,42:1063-1067.
［7］Gelblum DY,Potters L,Ashley R,et al.Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.Int J Radiant Oncol Biol Phys,1999,45:57-67.
［8］Nakao A,Kaneko T.Intravascullar ultrasonography for assessment of portal vein invsion by pancreatic carcinoma.World J Surg,1999,23(9):892-895.
［9］张凯,傅军,张伟,等.ATP生物荧光法技术在卵巢癌体外药物敏感性检测中的应用.癌症进展,2003,1(1):37-41.
［10］Kornmann M,Beger HG,Link KH.Chemosensitivity testing and test-directed chemotherapy in human pancreatic cancer.Recent Results Cancer Res,2003,161:180-195.
［11］Rosty C,Christa L,Kuzdzal S,et al.Identification of hepatocacinoma-intestine-pancreas/pancreatistis-associated protein Ⅰ as a biomarker for pancreatic ductal adenoma by protein biochip technology.Cancer Res,2002,62:1868-1875.